Pfizer's $829 Million Trading Day Ranks 100th Amid Board Investigation and Stock Decline

On June 3, 2025, Pfizer's trading volume reached $829 million, ranking 100th in the day's market activity. The stock experienced a 0.47% decline, marking its second consecutive day of losses, with a total decrease of 0.60% over the past two days.

Berger Montague PC has initiated an investigation into Pfizer's Board of Directors, focusing on whether the board breached its fiduciary duties in overseeing the company's operations. This investigation could potentially impact investor confidence and the company's stock performance.